In 1981, Dr. Sanghvi received his Ph.D. in organic chemistry from National Chemical Laboratory (Pune, India). From 1982 – 1985, his post-doctoral research was carried out at University of London with Professor C.B. Reese. In 1986, he joined ICN Pharmaceuticals, California. From 1989 – 2003, he worked at Ionis Pharmaceuticals, California. In 2003, he founded Rasayan Inc., a company focused on the consulting, outsourcing services and supply of products related to the nucleic acid field.  Dr. Sanghvi is also a founding member of Sapala Organics, a CRO/CMO located in Hyderabad, India. His specific interests include design, synthesis, chemistry and biochemistry of novel carbohydrates, nucleosides, nucleotides, and oligonucleotides for their application in therapeutics, combinatorial chemistry, and medical diagnostic research.

Dr. Sanghvi have co-authored over 200 scientific publications in leading journals, including several book chapters and have co-inventorship of more than 40 patents. He is an editor of two books entitled Carbohydrate Modifications in Antisense Research and Palladium-Catalyzed Modification of Nucleosides, Nucleotides and Oligonucleotides. He is also a member of editorial board for Current Protocols in Nucleic Acid Chemistry, a Wiley publication.